American Well (NYSE:AMWL) Insider Phyllis Gotlib Sells 3,573 Shares of Stock

American Well Corporation (NYSE:AMWL) insider Phyllis Gotlib sold 3,573 shares of the firm’s stock in a transaction that occurred on Monday, June 1st. The stock was sold at an average price of $9.74, for a total transaction of $34,801.02. Following the sale, the insider directly owned 159,431 shares in the company, valued at $1,552,857.94. The trade was a 2.19% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink.

Phyllis Gotlib also recently made the following trade(s):

• On Wednesday, April 1st, Phyllis Gotlib sold 3,706 shares of American Well stock. The stock was sold at an average price of $5.30, for a total transaction of $19,641.80.

American Well Price Performance

Shares of NYSE AMWL opened at $8.35 on Thursday. The stock has a market capitalization of $138.21 million, a price-to-earnings ratio of -1.54 and a beta of 1.69. American Well Corporation has a 12 month low of $3.71 and a 12 month high of $9.96. The firm’s 50 day simple moving average is $6.80 and its 200-day simple moving average is $5.51.

American Well (NYSE:AMWL) last issued its quarterly earnings data on Tuesday, May 5th. The company reported ($0.66) EPS for the quarter, topping analysts’ consensus estimates of ($0.77) by $0.11. American Well had a negative net margin of 37.02% and a negative return on equity of 32.11%. The business had revenue of $54.88 million for the quarter, compared to analysts’ expectations of $51.54 million. Analysts anticipate that American Well Corporation will post -2.68 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several equities analysts have issued reports on the stock. Wall Street Zen raised shares of American Well from a “sell” rating to a “hold” rating in a report on Sunday, March 22nd. TD Cowen increased their price objective on shares of American Well from $5.00 to $8.00 and gave the company a “hold” rating in a report on Wednesday, May 6th. Morgan Stanley increased their price objective on shares of American Well from $6.00 to $6.50 and gave the company an “equal weight” rating in a report on Wednesday, May 6th. Finally, Stifel Nicolaus decreased their price objective on shares of American Well from $6.00 to $5.00 and set a “hold” rating on the stock in a report on Friday, February 13th. One investment analyst has rated the stock with a Buy rating, three have assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Hold” and an average target price of $7.13.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in AMWL. Senvest Management LLC lifted its holdings in American Well by 213.3% in the 1st quarter. Senvest Management LLC now owns 1,136,558 shares of the company’s stock valued at $5,978,000 after purchasing an additional 773,834 shares in the last quarter. Hsbc Holdings PLC lifted its holdings in American Well by 186.6% in the 4th quarter. Hsbc Holdings PLC now owns 46,565 shares of the company’s stock valued at $224,000 after purchasing an additional 30,316 shares in the last quarter. NewEdge Advisors LLC purchased a new position in American Well in the 4th quarter valued at $82,000. XTX Topco Ltd purchased a new position in American Well in the 4th quarter valued at $215,000. Finally, Occudo Quantitative Strategies LP purchased a new position in American Well in the 4th quarter valued at $74,000. Hedge funds and other institutional investors own 56.05% of the company’s stock.

About American Well

American Well, operating under the trade name Amwell, is a Boston-based digital health company that develops and delivers telehealth solutions to healthcare providers, payers, employers and patients. Through its cloud-based platform, the company enables secure virtual visits, remote patient monitoring and integrated care coordination across a range of medical disciplines, including primary care, behavioral health, chronic disease management and urgent care.

The company’s core offering, the Amwell Telehealth Platform, facilitates live video consultations, asynchronous messaging, e-prescribing and electronic health record integration.